Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial

Background. During the past 20 years, some large international studies have been conducted that evaluated the effectiveness of treatment programs for children with medulloblastoma. At the same time, in the standard risk group, fairly high rates of 5-year overall survival (OS) and event-free survival...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Andrei S. Levashov, Svetlana R. Zagidullina, Anna M. Stroganova, Dmitrii A. Khochenkov, Marina V. Ryzhova, Sergei K. Gorelyshev, Shavkat U. Kadirov, Stepan S. Babelyan, Vasilii A. Grigorenko, Dmitrii A. Sidel’nikov, Natalia N. Subbotina, Vidmante V. Daylidite, Georgii L. Mentkevich
Format:	article
Langue:	RU
Publié:	IP Habib O.N. 2020
Sujets:	children medulloblastoma standard and high risk group craniospinal radiation high-dose chemotherapy molecular biological factors prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/a12eb34ca0b74cc593911e1f8ebacdcb
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial

Documents similaires